Research Output per year
Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.
- 2 Similar Profiles
Neoplasms
Medicine & Life Sciences
Conflict of Interest
Medicine & Life Sciences
Pharmaceutical Preparations
Medicine & Life Sciences
Antineoplastic Agents
Medicine & Life Sciences
Drug Approval
Medicine & Life Sciences
Medicine
Medicine & Life Sciences
United States Food and Drug Administration
Medicine & Life Sciences
Evidence-Based Medicine
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 2009 2018
Accounting for All Costs in the Total Cost of Chimeric Antigen Receptor T-Cell Immunotherapy - Reply
Hernandez, I., Prasad, V. & Gellad, W. F., Jan 1 2018, (Accepted/In press) In : JAMA Oncology.Research output: Contribution to journal › Article
T-Cell Antigen Receptor
Immunotherapy
Costs and Cost Analysis
1
Citations
A comprehensive review of exceptional responders to anticancer drugs in the biomedical literature
Nishikawa, G., Luo, J. & Prasad, V., Sep 1 2018, In : European Journal of Cancer. 101, p. 143-151 9 p.Research output: Contribution to journal › Article
Pharmaceutical Preparations
Neoplasms
History
Drug Therapy
Conflict of Interest
Addendum: Low-value approvals and high prices might incentivize ineffective drug development
Prasad, V., McCabe, C. & Mailankody, S., Jan 1 2018, (Accepted/In press) In : Nature Reviews Clinical Oncology.Research output: Contribution to journal › Article
Pharmaceutical Preparations
Costs and Cost Analysis
A pooled analysis of published, basket trials in cancer medicine
Hazim, A. & Prasad, V., Sep 1 2018, In : European Journal of Cancer. 101, p. 244-250 7 p.Research output: Contribution to journal › Article
Medicine
Neoplasms
Fallopian Tube Neoplasms
Thymus Neoplasms
Seminoma
Brentuximab vedotin for frontline Hodgkin lymphoma: How much will a successful trial cost patients and payers?
Shanbhag, S. & Prasad, V., Nov 1 2018, In : European Journal of Cancer. 104, p. 252-253 2 p.Research output: Contribution to journal › Letter
Hodgkin Disease
Costs and Cost Analysis
cAC10-vcMMAE